• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe newsletter
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

Queen’s University Belfast leads project to revolutionise drug delivery

, 15 December 2021/in E-News /by panglobal

Queen’s University Belfast are leading a £1.2 million project to improve drug delivery for a range of illnesses. The grant, awarded by the Engineering and Physical Sciences Research Council, part of the UK Research and Innovation, is expected to accelerate the development of microarray patches for drug delivery and make them available to patients worldwide.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/12/Ryan-Donnelly.jpg 665 1000 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-12-15 15:45:122021-12-15 15:45:12Queen’s University Belfast leads project to revolutionise drug delivery

The BMJ joins forces with Cochrane Sustainable Health-care to launch The Recovery

, 15 December 2021/in E-News /by panglobal

The BMJ has joined forces with Cochrane Sustain- able Healthcare to launch a new podcast series called ‘The Recovery’ co-hosted by The BMJ’s Editor in Chief Dr Fiona Godlee and journalist and Bond University health researcher Dr Ray Moynihan.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/12/shutterstock_618279875-kopiëren.jpg 773 699 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-12-15 15:42:272021-12-15 15:42:27The BMJ joins forces with Cochrane Sustainable Health-care to launch The Recovery

World Health Assembly agrees to develop historic global accord on pandemic prevention

, 15 December 2021/in E-News /by panglobal

In a consensus decision aimed at protecting the world from future infectious diseases crises, the World Health Assembly on 1 December 2021 agreed to kickstart a global process to draft and negotiate a convention under the Constitution of the World Health Organization to strengthen pandemic prevention, preparedness and response.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/12/WHO-Meet.jpg 511 1000 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-12-15 15:38:332021-12-15 15:38:33World Health Assembly agrees to develop historic global accord on pandemic prevention

WHO, MPP announce first global, non-exclusive licence for a COVID-19 serological antibody technology

, 15 December 2021/in E-News /by panglobal

WHO’s COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP) have finalized a licensing agreement with the Spanish National Research Council (CSIC) for a COVID-19 serological antibody technology. The test effectively checks for the presence of anti-SARS-CoV-2 antibodies developed either in response to a COVID-19 infection or to a vaccine. This represents the […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/12/covid33.jpg 667 1000 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-12-15 15:36:102021-12-21 12:27:11WHO, MPP announce first global, non-exclusive licence for a COVID-19 serological antibody technology

Thrombolytic Science granted US patent for novel, nature-inspired clot-dissolving therapy

, 15 December 2021/in E-News /by panglobal

Thrombolytic Science (TSI) has been granted a new patent by the USPTO for an invention that relates to methods for a safe and effective clot dissolution that mimics the natural biological system. Most strokes and all heart attacks are caused by a blood clot blocking essential blood flow to a portion of the brain or […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/12/shutterstock_1289382880.jpg 667 1000 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-12-15 15:33:442021-12-21 12:26:19Thrombolytic Science granted US patent for novel, nature-inspired clot-dissolving therapy

FDA approves first treatment for common type of post-transplant infection that is resistant to other drugs

, 15 December 2021/in E-News /by panglobal

The U.S. FDA has approved Takeda Pharmaceuticals’ Livtencity (maribavir) as the first drug for treating adults and paediatric patients (12 years of age and older and weighing at least 35 kilograms) with post-transplant cytomegalovirus (CMV) infection that does not respond to available antiviral treatment for CMV. Livtencity works by preventing the activity of human cytomegalovirus […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/12/shutterstock_288923126.jpg 546 1000 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-12-15 15:31:582021-12-15 15:31:58FDA approves first treatment for common type of post-transplant infection that is resistant to other drugs

Cambridgeshire and Peterborough to build shared care record with Orion Health

, 15 December 2021/in E-News /by panglobal

The United Kingdom’s Cambridgeshire and Peterborough’s integrated care system has signed an eight-year contract with Orion Health to develop a shared care record that will be used by eight health and care organisations and all the GP practices in its area.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/12/orion-record.png 596 1004 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-12-15 15:29:312021-12-15 15:29:31Cambridgeshire and Peterborough to build shared care record with Orion Health

CDC to invest $26 million in advanced outbreak forecasting and analytics

, 15 December 2021/in E-News /by panglobal

The United States Centers for Disease Control and Prevention (CDC) will invest $26 million in funding to develop next-generation infectious disease forecasting and analytics. The agency will provide $21 million to support research and development of advanced infectious disease models and analytical tools. The awards will support three years of work at five leading academic […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/12/data_CDC.jpg 667 1000 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-12-15 15:27:132021-12-15 15:27:13CDC to invest $26 million in advanced outbreak forecasting and analytics

Hologic completes acquisition of Bolder Surgical

, 15 December 2021/in E-News /by panglobal

Hologic, a global leader in women’s health, has completed its acquisition of Bolder Surgical, a privately held, U.S.-based company that provides advanced energy vessel sealing surgical devices.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/11/hologic_logo-1.png 860 1878 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-12-15 15:24:332021-12-15 15:24:33Hologic completes acquisition of Bolder Surgical

Canon Medical, Resoundant sign licencing deal for Magnetic Resonance Elastography on Canon MRI platforms

, 15 December 2021/in E-News /by Canon Medical Systems Europe

Canon Medical Systems and Resoundant have signed a licensing agreement for the purpose of incorporating the advanced Magnetic Resonance Elastography (MRE), developed by Resoundant on the Canon MRI platforms. Canon Medical and Resoundant have been working closely together to implement a seamless integration of the latest MRE technology on Canon’s newest line of MRI scanners.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/12/canon_logo.png 488 1384 Canon Medical Systems Europe https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png Canon Medical Systems Europe2021-12-15 15:22:592021-12-15 15:22:59Canon Medical, Resoundant sign licencing deal for Magnetic Resonance Elastography on Canon MRI platforms
Page 44 of 231«‹4243444546›»

Latest issue of International Hospital

April 2024

4 July 2025

Everdrone expands world-first medical emergency drone network in Sweden

4 July 2025

Wireless implant breakthrough offers personalised chronic pain relief

3 July 2025

EEG-powered brain computer interface enables finger-level robotic hand control

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription